West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Toronto Dominion Bank

Toronto Dominion Bank trimmed its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 15.1% during the second quarter, Holdings Channel reports. The firm owned 35,911 shares of the medical instruments supplier’s stock after selling 6,364 shares during the quarter. Toronto Dominion Bank’s holdings in West Pharmaceutical Services were worth $11,829,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of WST. Fidelis Capital Partners LLC acquired a new position in West Pharmaceutical Services during the 1st quarter worth about $27,000. Crewe Advisors LLC increased its stake in West Pharmaceutical Services by 322.7% during the second quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 71 shares during the period. Quarry LP boosted its stake in shares of West Pharmaceutical Services by 155.3% in the fourth quarter. Quarry LP now owns 97 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 59 shares during the period. Hazlett Burt & Watson Inc. acquired a new position in shares of West Pharmaceutical Services in the first quarter valued at approximately $40,000. Finally, Northwest Investment Counselors LLC purchased a new stake in West Pharmaceutical Services during the 1st quarter worth approximately $40,000. 93.90% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other West Pharmaceutical Services news, VP Charles Witherspoon sold 1,029 shares of the business’s stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $300.00, for a total transaction of $308,700.00. Following the completion of the transaction, the vice president now owns 1,478 shares in the company, valued at approximately $443,400. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.53% of the company’s stock.

West Pharmaceutical Services Stock Performance

Shares of WST stock opened at $311.00 on Friday. The firm has a 50 day moving average of $301.92 and a two-hundred day moving average of $335.70. The stock has a market capitalization of $22.56 billion, a PE ratio of 41.03, a P/E/G ratio of 11.04 and a beta of 1.01. The company has a quick ratio of 1.68, a current ratio of 2.34 and a debt-to-equity ratio of 0.03. West Pharmaceutical Services, Inc. has a 52 week low of $265.00 and a 52 week high of $413.70.

West Pharmaceutical Services (NYSE:WST) last released its earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 EPS for the quarter, missing the consensus estimate of $1.74 by ($0.22). The company had revenue of $702.10 million for the quarter, compared to analyst estimates of $729.36 million. West Pharmaceutical Services had a return on equity of 19.17% and a net margin of 18.25%. The company’s revenue for the quarter was down 6.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $2.11 earnings per share. On average, research analysts predict that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current fiscal year.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.